Investigational study of ustekinumab in the treatment of psoriatic arthritis published
Thursday, February 12, 2009 - 06:42
in Health & Medicine
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomised, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA). The Phase 2 study was published in the British medical journal The Lancet...
Read the whole article on Science Centric
More from Science Centric
Related
- Investigational study of ustekinumab in the treatment of psoriatic arthritis publishedThu, 12 Feb 2009, 6:46:00 EST
- New drug shows promising results for psoriatic arthritisTue, 7 Apr 2009, 13:29:37 EDT
- First international guidelines for treatment of psoriatic arthritisSun, 26 Oct 2008, 12:08:35 EDT
- Risk of tuberculosis from arthritis medication examinedTue, 30 Jun 2009, 18:42:30 EDT
- Diagnosis of arthritis 5 years earlier in childless women compared to those with childrenFri, 12 Jun 2009, 10:08:52 EDT